Known for its nasal spray offering rapid onset to treat ED, LTR Pharma is expanding its portfolio while aiming for a swift ride to market.

Kye Pharmaceuticals (“Kye”) announced today that Health Canada has approved AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) in ...

Medics from the Wisconsin Air National Guard’s 115th Fighter Wing are training at University Hosptial, as part of a new partnership with UW Health.

However, the 2025-26 academic year marks the launch of a new, 21st-century Doctor of Philosophy in Public Health degree with a concentration in health services research and implementation science that ...

The firm will use the funding to launch its T-cell engager candidate into clinical trials early next year in LY6G6D-expressing colorectal cancer.

This story by Stephanie Armour and Julie Rovner, KFF Health News, and Amanda Seitz, Arielle Zionts and Rachana Pradhan appeared on KFF Health News on October 1, 2025. Threats of a federal government ...